Home > Qtrly Results > MARKSANS PHARMA

MARKSANS PHARMA
Quarterly Results Analysis [Dec2025]

MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MARKSANS PHARMA Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹754 Cr ₹720 Cr ₹620 Cr ₹708 Cr ₹682 Cr ₹642 Cr ₹591 Cr ₹560 Cr
Expenses ₹594 Cr ₹576 Cr ₹520 Cr ₹583 Cr ₹551 Cr ₹495 Cr ₹462 Cr ₹450 Cr
Operating Income ₹161 Cr ₹144 Cr ₹100 Cr ₹126 Cr ₹131 Cr ₹147 Cr ₹128 Cr ₹110 Cr
Other Income ₹20 Cr ₹22 Cr ₹6 Cr ₹17 Cr ₹36 Cr ₹0 Cr ₹15 Cr ₹17 Cr
Interest ₹6 Cr ₹6 Cr ₹6 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹5 Cr
Depreciation ₹24 Cr ₹27 Cr ₹23 Cr ₹23 Cr ₹21 Cr ₹20 Cr ₹20 Cr ₹21 Cr
Profit Before Tax ₹151 Cr ₹133 Cr ₹77 Cr ₹116 Cr ₹143 Cr ₹125 Cr ₹120 Cr ₹100 Cr
Profit After Tax ₹114 Cr ₹99 Cr ₹58 Cr ₹91 Cr ₹105 Cr ₹98 Cr ₹89 Cr ₹78 Cr
EPS ₹2.50 ₹2.17 ₹1.29 ₹2.00 ₹2.31 ₹2.13 ₹1.96 ₹1.73
Industry Peers & Returns1W1M1Y
MARKSANS PHARMA 7.8% -2.9% -27%
SUN PHARMACEUTICAL INDUSTRIES 4% -4.9% -2.3%
DIVIS LABORATORIES 1.1% -9.3% 9.1%
CIPLA 1.5% -9.3% -7.3%
TORRENT PHARMACEUTICALS -1.3% -3.7% 24%
DR REDDYS LABORATORIES 5% -0.1% 3.3%
MANKIND PHARMA -0.4% -10.9% -16.1%
ZYDUS LIFESCIENCES 1% -4.2% -7%
LUPIN 1.9% -2% 7.9%

MARKSANS PHARMA Quarterly Revenues

Revenues
Q-o-Q

4.72 %

Y-o-Y

10.64 %

Quarters Revenues % Change
Dec2025 ₹754 Cr
4.72
Sep2025 ₹720 Cr
16.20
Jun2025 ₹620 Cr
-12.49
Mar2025 ₹708 Cr
3.90
Dec2024 ₹682 Cr
6.22
Sep2024 ₹642 Cr
8.69
Jun2024 ₹591 Cr
5.47
Mar2024 ₹560 Cr -

MARKSANS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

11.25 %

Y-o-Y

23.17 %

Quarters Operating Profit % Change
Dec2025 ₹161 Cr
11.25
Sep2025 ₹144 Cr
44.32
Jun2025 ₹100 Cr
-20.38
Mar2025 ₹126 Cr
-3.64
Dec2024 ₹131 Cr
-11.11
Sep2024 ₹147 Cr
14.31
Jun2024 ₹128 Cr
17.14
Mar2024 ₹110 Cr -
Operating Margins
Q-o-Q

6.23 %

Y-o-Y

11.34 %

Quarters Operating Margin% % Change
Dec2025 21.31%
6.23
Sep2025 20.06%
24.21
Jun2025 16.15%
-9.01
Mar2025 17.75%
-7.26
Dec2024 19.14%
-16.31
Sep2024 22.87%
5.15
Jun2024 21.75%
11.08
Mar2024 19.58% -

MARKSANS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

14.68 %

Y-o-Y

8.21 %

Quarters Profit After Tax % Change
Dec2025 ₹114 Cr
14.68
Sep2025 ₹99 Cr
70.34
Jun2025 ₹58 Cr
-35.85
Mar2025 ₹91 Cr
-13.65
Dec2024 ₹105 Cr
7.47
Sep2024 ₹98 Cr
9.76
Jun2024 ₹89 Cr
14.71
Mar2024 ₹78 Cr -
PAT Margins
Q-o-Q

9.52 %

Y-o-Y

-2.21 %

Quarters PAT Margin(%) % Change
Dec2025 15.07 %
9.52
Sep2025 13.76 %
46.54
Jun2025 9.39 %
-26.70
Mar2025 12.81 %
-16.87
Dec2024 15.41 %
1.18
Sep2024 15.23 %
0.99
Jun2024 15.08 %
8.80
Mar2024 13.86 % -

MARKSANS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

15.21 %

Y-o-Y

8.23 %

Quarters EPS % Change
Dec2025 ₹2.5
15.21
Sep2025 ₹2.17
68.22
Jun2025 ₹1.29
-35.50
Mar2025 ₹2
-13.42
Dec2024 ₹2.31
8.45
Sep2024 ₹2.13
8.67
Jun2024 ₹1.96
13.29
Mar2024 ₹1.73 -

You may also like the below Video Courses